- About PMI
  - Welcome to PMI Science
  - Our Scientists
  - The Cube: PMI’s R&D Center
  - Our Network
- Smoke-free approach
  - What Is Harm Reduction?
  - Absence of Combustion
  - Nicotine
  - The Role of Smoke-Free Products
  - Tar
  - Tobacco Regulation
  - Harmful Chemicals Measured
- Research
  - PMI’s Studies on Smoke-Free Products
  - Our Findings
  - PMI Publications Library
  - Literature Reviews
  - Independent Studies
  - Investigator Initiated Studies (IIS)
  - PMI Science Booklet
  - Facts and Figures on Our Smoke-Free Future
- Our Products
  - Tobacco Heating System
  - Oven Heating System
  - Ceramic Vaping System
  - Disposable Vaping System
  - Oral Nicotine Pouches
  - Nicotine Salts Product
- News & Events
  - Scientific Update Magazine
  - Open Science Events
  - News
  - Conferences Calendar
- Contact Us

News | Investigator Initiated Studies | Updated on May 15, 2023

Investigator Initiated Studies Program Publications

As part of our Investigator Initiated Studies (IIS) program, Philip Morris International (PMI) embraces transparency and open access, just as we do for the research we conduct as part of our assessment program. Learn more about the supported studies under the IIS program, and review the publications produced by investigators supported by this program in the table below:

Group of people gathered around and looking at a computer.

Supported Investigator Initiated Studies

PMI invites investigators to submit proposals under our Investigator Initiated Studies (IIS). See the studies that have already been supported.

Investigator Initiated Studies (IIS)

Learn more about PMI's Investigator Initiated Studies program and see how to submit your proposal.

A scientist holds a pipette with rubber gloves.

Research

Explore our product assessment program, its results, and the publications where they are published. Find a wealth of independent research and expert reports.

PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization.

Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.